This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB02537/identifier/pdb/
n10http://bio2rdf.org/drugbank:
n5http://linked.opendata.cz/resource/drugbank/drug/DB02537/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB02537/identifier/pubchem-substance/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02537/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02537
rdf:type
n6:Drug
n6:group
experimental
owl:sameAs
n9:DB02537 n10:DB02537
dcterms:title
2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine
adms:identifier
n4:MBQ n5:46936418 n12:DB02537 n13:46509095
n6:IUPAC-Name
n7:271B406E-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B4074-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B4073-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B4070-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B4071-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B4072-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B406C-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B406A-363D-11E5-9242-09173F13E4C5 n7:271B406D-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B406B-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Acceptor-Count
n7:271B407A-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B407B-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B4075-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B4076-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B4078-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B4077-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B4079-363D-11E5-9242-09173F13E4C5
n6:Bioavailability
n7:271B4080-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B4082-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B4083-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B407F-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B407E-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B4081-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B406F-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B407C-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B407D-363D-11E5-9242-09173F13E4C5